Back to Search
Start Over
Adalimumab Biosimilars Insight Report, 2020 by DelveInsight
- Source :
- M2 Presswire. April 27, 2021
- Publication Year :
- 2021
-
Abstract
- M2 PRESSWIRE-April 27, 2021-: Adalimumab Biosimilars Insight Report, 2020 by DelveInsight (C)1994-2021 M2 COMMUNICATIONS RDATE:26042021 DelveInsight's, 'Adalimumab Biosimilar Insight, 2020,' report provides comprehensive insights about 35+ companies and 45+ marketed [...]
- Subjects :
- Pfizer Inc. -- Forecasts and trends
Psoriasis -- Forecasts and trends -- Reports
Rheumatoid factor -- Reports -- Forecasts and trends
Homeopathy -- Materia medica and therapeutics
Therapeutics -- Forecasts and trends -- Reports
Arthritis -- Reports -- Forecasts and trends
Adalimumab -- Forecasts and trends -- Reports
Pharmaceutical industry -- Forecasts and trends
Market trend/market analysis
Business
Business, international
Humira (Medication) -- Reports
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.659749835